Nls Pharmaceutics Ag Stock Probability of Future Stock Price Finishing Over 98.86
| NLSPW Stock | USD 0.01 0 7.69% |
NLS |
NLS Pharmaceutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NLS Pharmaceutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NLS Pharmaceutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NLS Pharmaceutics is way too risky over 90 days horizon | |
| NLS Pharmaceutics has some characteristics of a very speculative penny stock | |
| NLS Pharmaceutics appears to be risky and price may revert if volatility continues | |
| NLS Pharmaceutics has high likelihood to experience some financial distress in the next 2 years | |
| NLS Pharmaceutics AG has accumulated 1.63 M in total debt. NLS Pharmaceutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about NLS Pharmaceutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (12.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NLS Pharmaceutics AG has accumulated about 145.4 K in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
NLS Pharmaceutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NLS Stock often depends not only on the future outlook of the current and potential NLS Pharmaceutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NLS Pharmaceutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.2 M | |
| Cash And Short Term Investments | 897.7 K |
NLS Pharmaceutics Technical Analysis
NLS Pharmaceutics' future price can be derived by breaking down and analyzing its technical indicators over time. NLS Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NLS Pharmaceutics AG. In general, you should focus on analyzing NLS Stock price patterns and their correlations with different microeconomic environments and drivers.
NLS Pharmaceutics Predictive Forecast Models
NLS Pharmaceutics' time-series forecasting models is one of many NLS Pharmaceutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NLS Pharmaceutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NLS Pharmaceutics
Checking the ongoing alerts about NLS Pharmaceutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NLS Pharmaceutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NLS Pharmaceutics is way too risky over 90 days horizon | |
| NLS Pharmaceutics has some characteristics of a very speculative penny stock | |
| NLS Pharmaceutics appears to be risky and price may revert if volatility continues | |
| NLS Pharmaceutics has high likelihood to experience some financial distress in the next 2 years | |
| NLS Pharmaceutics AG has accumulated 1.63 M in total debt. NLS Pharmaceutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about NLS Pharmaceutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (12.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NLS Pharmaceutics AG has accumulated about 145.4 K in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Additional Tools for NLS Stock Analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.